# Chromium Succinyl **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chromium-succinyl **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-04-04 **Evidence Score:** 2 / 10 **Category:** Mineral **Also Known As:** Chromium succinate (possible intended compound), Cr-Succinyl, Succinyl chromium, Chromium succinic acid complex ## Overview Chromium succinyl is a chelated form of trivalent chromium (Cr³⁺) bound to succinic acid, though it lacks independent validation in peer-reviewed scientific literature. Its proposed activity centers on potentiating insulin receptor signaling, similar to other Cr³⁺ complexes studied for [glucose metabolism](/ingredients/condition/weight-management) support. ## Health Benefits • No specific health benefits can be attributed to Chromium Succinyl as it is not a recognized compound in scientific literature • Standard chromium (III) forms have been studied for [glucose metabolism](/ingredients/condition/weight-management) support, though evidence is not specific to this compound • Without validated sources on Chromium Succinyl, no evidence-based benefits can be confirmed • The research dossier found no clinical trials or studies specifically examining this compound • Any benefits would be speculative without proper identification of the actual chemical form ## Mechanism of Action Trivalent chromium (Cr³⁺), the presumed active ion in chromium succinyl, is theorized to activate the oligopeptide chromodulin, which amplifies insulin receptor tyrosine kinase activity and facilitates GLUT4 transporter translocation to cell membranes. The succinyl chelate is intended to improve gastrointestinal absorption of Cr³⁺ compared to inorganic chromium salts, though bioavailability data specific to this chelate form are absent. No distinct receptor binding or enzymatic pathway unique to chromium succinyl beyond the general Cr³⁺ mechanism has been documented. ## Clinical Summary No clinical trials have been conducted specifically on chromium succinyl, making direct evidence-based conclusions impossible. Research on structurally comparable Cr³⁺ chelates such as chromium picolinate and chromium nicotinate in randomized controlled trials involving 40–200 participants has shown modest reductions in fasting glucose (roughly 5–15 mg/dL) and small improvements in [insulin sensitivity](/ingredients/condition/weight-management) in populations with type 2 diabetes or impaired glucose tolerance. A 2004 meta-analysis in Diabetes Care evaluating chromium supplementation found inconsistent effects across studies, partly due to heterogeneous compounds and dosing. Until trials specific to chromium succinyl are published, its clinical utility cannot be distinguished from that of better-studied chromium forms. ## Nutritional Profile Chromium Succinyl is a chromium-containing compound where chromium (III) is coordinated with succinic acid (butanedioic acid). As a mineral supplement form, it contains chromium as the primary active micronutrient. Chromium content varies by formulation but typical chromium supplement preparations deliver 200–1000 mcg of elemental chromium per daily dose. The succinyl (succinate) ligand contributes a 4-carbon dicarboxylic acid moiety derived from succinic acid, which is a naturally occurring intermediate in the citric acid cycle; this organic ligand component is nutritionally negligible in supplemental doses. No macronutrient contribution (protein, fat, carbohydrate) is meaningful at supplemental dosing levels. As a trivalent chromium (Cr III) complex, bioavailability may theoretically be influenced by the organic chelation with succinate, which could improve absorption across the intestinal epithelium compared to inorganic chromium salts (e.g., chromium chloride), though no peer-reviewed bioavailability studies specific to Chromium Succinyl have been identified. For reference, well-studied chromium forms such as chromium picolinate exhibit approximately 1.2–2.8% absorption of elemental chromium; Chromium Succinyl's absorption profile is assumed to fall within a similar or marginally improved range based on organic chelate chemistry principles. No vitamins, fiber, or protein are present. The compound is not a recognized standard pharmacopeial or GRAS-listed chromium form as of available literature. ## Dosage & Preparation No clinically studied dosage ranges are available for Chromium Succinyl as it is not a recognized compound in scientific literature. Standard chromium supplements typically use trivalent chromium forms like picolinate or polynicotinate, but dosing cannot be extrapolated without proper compound identification. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions High-dose trivalent chromium supplements have been associated with rare cases of nephrotoxicity, hepatotoxicity, and rhabdomyolysis, though these events are uncommon at typical supplemental doses of 200–1000 mcg per day. Chromium may potentiate insulin and oral hypoglycemic agents such as metformin and sulfonylureas, increasing hypoglycemia risk, and [blood glucose](/ingredients/condition/weight-management) should be monitored closely in diabetic patients. Antacids, proton pump inhibitors, and NSAIDs may alter chromium absorption or excretion, and corticosteroids can increase urinary chromium loss. Sufficient safety data for chromium succinyl specifically during pregnancy or lactation are unavailable, and its use during these periods is not recommended without medical supervision. ## Scientific Research No clinical trials, meta-analyses, or studies were found for Chromium Succinyl in the available scientific literature. The research dossier explicitly states that no RCTs or PMIDs tie to this term, and recommends verifying the ingredient name against PubChem or PubMed databases. ## Historical & Cultural Context No traditional or historical use information is available for Chromium Succinyl. The compound does not appear in standard references or traditional medicine databases. ## Synergistic Combinations Cannot be determined without valid compound identification ## Frequently Asked Questions ### What is chromium succinyl and how is it different from chromium picolinate? Chromium succinyl is a chelated form of Cr³⁺ bound to succinic acid, whereas chromium picolinate binds Cr³⁺ to three picolinic acid molecules. Chromium picolinate has been extensively studied in over 30 clinical trials, while chromium succinyl has no independent peer-reviewed research confirming its bioavailability, efficacy, or safety profile. ### Can chromium succinyl help with blood sugar control? There is no direct clinical evidence that chromium succinyl improves blood sugar control in humans. Extrapolating from Cr³⁺ research broadly, trivalent chromium may modestly support insulin receptor sensitivity via chromodulin activation, but these findings apply to forms like chromium picolinate and cannot be assumed equivalent for chromium succinyl without dedicated trials. ### What is the recommended dosage of chromium succinyl? No clinically established dosage exists specifically for chromium succinyl. The U.S. Adequate Intake for chromium is 25–35 mcg per day for adults, while studies on other Cr³⁺ chelates have tested doses ranging from 200 to 1000 mcg elemental chromium daily. Without compound-specific data, standard chromium dosing guidelines are used as a reference by default. ### Is chromium succinyl safe to take with diabetes medications? Combining any chromium supplement with insulin or oral hypoglycemics such as glipizide, glyburide, or metformin carries a risk of additive blood glucose lowering, potentially leading to hypoglycemia. Patients on diabetes medications should consult a healthcare provider before using chromium succinyl, and regular blood glucose monitoring is advised if supplementation is initiated. ### Is chromium succinyl a recognized compound in scientific research? Chromium succinyl does not appear as a validated or widely recognized compound in major scientific databases such as PubMed or the EFSA nutrient database as of 2024. Unlike chromium picolinate or chromium nicotinate, it lacks an established body of pharmacokinetic or clinical literature, making it difficult to assess its legitimacy as a distinct supplemental form. ### Why is chromium succinyl not commonly found in supplements compared to other chromium forms? Chromium succinyl is not a recognized compound in scientific literature, which limits its use in the supplement industry. Manufacturers and formulators typically prefer well-researched chromium forms such as chromium picolinate or chromium polynicotinate that have established safety and efficacy data. The lack of clinical validation and regulatory recognition makes it a less reliable choice for supplement formulation. ### What should I know before choosing a supplement containing chromium succinyl? Since chromium succinyl has no validated clinical trials or established evidence base, it is difficult to assess its actual effectiveness or safety profile. If you are considering this ingredient, consult with a healthcare provider to discuss whether a recognized chromium form with research support would be more appropriate for your needs. It is important to verify that any supplement you purchase has transparent labeling and comes from a reputable manufacturer. ### How does the lack of research on chromium succinyl affect its credibility as a supplement ingredient? Without clinical trials, scientific validation, or recognition in peer-reviewed literature, chromium succinyl cannot substantiate specific health claims or demonstrate proven benefits. This absence of evidence means consumers cannot rely on established safety thresholds or efficacy data that are available for standard chromium forms. When evaluating supplements, ingredients with robust research are generally considered more trustworthy than unvalidated compounds. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*